dc.contributor.author |
Kopp, Hans-Georg |
|
dc.date.accessioned |
2019-01-15T10:19:44Z |
|
dc.date.available |
2019-01-15T10:19:44Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
1471-2407 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/85653 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Biomed Central Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1186/s12885-016-2654-x |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20180405102126_01612 |
|
utue.personen.roh |
Schuler, Markus K. |
|
utue.personen.roh |
Gerdes, Sebastian |
|
utue.personen.roh |
West, Antje |
|
utue.personen.roh |
Richter, Stephan |
|
utue.personen.roh |
Busemann, Christoph |
|
utue.personen.roh |
Hentschel, Leopold |
|
utue.personen.roh |
Lenz, Felicitas |
|
utue.personen.roh |
Kopp, Hans-Georg |
|
utue.personen.roh |
Ehninger, Gerhard |
|
utue.personen.roh |
Reichardt, Peter |
|
utue.personen.roh |
Pink, Daniel |
|
dcterms.isPartOf.ZSTitelID |
Bmc Cancer |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 619 |
de_DE |
dcterms.isPartOf.ZS-Volume |
16 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |